Skip to main content
Equibles

GLENVIEW CAPITAL MANAGEMENT, LLC

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1138995 NEW YORK, NY
Back to TMO Full portfolio

Position in TMO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$314,473,046
+$191,332,493 QoQ
Shares Held
627,240
+150.4% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
6.28%
of 13F equity value
Holder Rank
#84
of 2,620 holders
Holding Since
Jun 2020
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

GLENVIEW CAPITAL MANAGEMENT, LLC holds $794,373,256 across 3 Diagnostics & Research names. TMO ranks #1 (39.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
This page 		627,240 $314,473,046
2 A
Agilent Technologies, Inc.
 1,969,541 $261,614,131
3 DHR
Danaher Corp /De/
 1,145,979 $218,286,079

All Filings in TMO

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $314,473,046 627,240
2026-03-31 $123,140,553 250,525
2025-12-31 $129,766,089 223,947
2025-09-30 $137,232,043 282,941
2025-06-30 $40,546,000 100,000
2020-06-30 $29,550,638 81,555